https://orcid.org/0000-0002-4872-6711
Overview
Dr. Crosby received her PhD in Immunology from the University of Pennsylvania where she used models of chronic infection to understand how the immune system causes damage to healthy tissue. She arrived at Duke for a postdoctoral fellowship where she applied this knowledge to test new therapies that bypass this immune system regulation to treat breast cancer. Dr. Crosby remained at Duke to start her own research program in 2021.
Current Appointments & Affiliations
Assistant Professor in Surgery
·
2021 - Present
Surgery, Surgical Sciences,
Surgery
Assistant Professor in Molecular Genetics and Microbiology
·
2023 - Present
Molecular Genetics and Microbiology,
Basic Science Departments
Assistant Professor in Integrative Immunobiology
·
2024 - Present
Integrative Immunobiology,
Basic Science Departments
Member of the Duke Cancer Institute
·
2023 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Abstract B041: GLP-1 receptor agonists associated with improved response to immune checkpoint inhibitors in solid tumors: a multi-institutional retrospective cohort study
Conference Cancer Immunology Research · February 18, 2026 AbstractIntroduction:Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly utilized for Type 2 Diabetes Mellitus ( ... Full text CiteAbstract C071: Obesity impairs anti-tumor responses to breast cancer vaccination
Conference Cancer Immunology Research · February 18, 2026 AbstractWhile advances in immunotherapy have improved treatment of breast cancer, many patients do not respond to current immunotherapies, there is not a reliable predictor of immunotherapy efficacy, and ... Full text CiteAbstract A005: Utility of an oncogene-driven spontaneous triple-negative breast cancer model for immunotherapeutic testing
Conference Cancer Immunology Research · February 18, 2026 AbstractOne in eight women will develop breast cancer in their lifetime and it is the second leading cause of cancer-related deaths among women. Breast cancer is a heterogeneous disease with multiple subt ... Full text CiteRecent Grants
Advanced Immunobiology Traning Program for Surgeons
Inst. Training Prgm or CMEMentor · Awarded by National Institute of Allergy and Infectious Diseases · 2019 - 2029Targeted vaccination against common resistance genes and neoepitope mutation drivers to treat and prevent endocrine-resistant ER+ Breast Cancer
ResearchCo Investigator · Awarded by Department of Defense · 2024 - 2027Spatial multiomic evaluation of clinical responders with advanced triple negative breast cancer from KEYNOTE-890 to validate a published CXCR3 gene signature
ResearchPrincipal Investigator · Awarded by Department of Defense · 2023 - 2027View All Grants
Education
University of Pennsylvania ·
2014
Ph.D.
Bucknell University ·
2009
B.S.